After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Niagen Bioscience Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Niagen Bioscience Inc is $559.03M. A total of 0.53 million shares were traded on the day, compared to an average of 879.12K shares.
In the most recent transaction, Lopez Carlos Luis bought 273 shares of NAGE for 7.86 per share on Mar 07 ’25. After the transaction, the SVP, General Counsel now owns 2,251 company shares. In a previous transaction on Dec 13 ’24, Jaksch Frank L Jr sold 37,161 shares at 6.19 per share. NAGE shares that Director owns now total 244,179.
Among the insiders who bought shares, Frank Jaksch Jr. acquired of 37,161 shares on Dec 13 ’24 at a per-share price of $6.19. In another insider transaction, Pamir Ozan bought 2,907 shares at $7.36 per share on Nov 22 ’24. Company shares held by the Chief Financial Officer now total 2,907.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. NAGE’s most recent ex-dividend date was $3.07 trillion when it declared a $204.57+2.4% quarterly dividend that was paid in cash on $234.17(14.5% Upside). Previously, the company paid the dividend on $494.80(32.1% Upside) with an ex-dividend date of $2.78 trillion. The NAGE stock dividend was $374.58+2.1% per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NAGE has a high of $9.18 and a low of $2.31.
As of this writing, NAGE has an earnings estimate of $0.02 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of $0.03 per share and a lower estimate of $0.0.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NAGE’s latest balance sheet shows that the firm has $28.02M in Cash & Short Term Investments as of fiscal 2021. There were $4.70M in debt and $17.61M in liabilities at the time. Its Book Value Per Share was $0.60, while its Total Shareholder’s Equity was $31.73M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NAGE is Buy with a score of 5.00.
